Darmiyan, Inc. has announced that it has closed a $6 million seed investment round led by the pharmaceutical giant Eisai, creating a major business collaboration opportunity between the two companies, one focused on advanced brain diagnostics, and the other focused on Alzheimer’s therapeutics. Other investors that took part in the funding round include IT-Farm and…